These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 15778730

  • 1. Haplotype mismatched transplantation using high doses of peripheral blood CD34+ cells together with stratified conditioning regimens for high-risk adult acute myeloid leukemia patients: a pilot study in a single Korean institution.
    Kim HJ, Min WS, Kim YJ, Kim DW, Lee JW, Kim CC.
    Bone Marrow Transplant; 2005 May; 35(10):959-64. PubMed ID: 15778730
    [Abstract] [Full Text] [Related]

  • 2. Full haplotype-mismatched hematopoietic stem-cell transplantation: a phase II study in patients with acute leukemia at high risk of relapse.
    Aversa F, Terenzi A, Tabilio A, Falzetti F, Carotti A, Ballanti S, Felicini R, Falcinelli F, Velardi A, Ruggeri L, Aloisi T, Saab JP, Santucci A, Perruccio K, Martelli MP, Mecucci C, Reisner Y, Martelli MF.
    J Clin Oncol; 2005 May 20; 23(15):3447-54. PubMed ID: 15753458
    [Abstract] [Full Text] [Related]

  • 3. Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype.
    Aversa F, Tabilio A, Velardi A, Cunningham I, Terenzi A, Falzetti F, Ruggeri L, Barbabietola G, Aristei C, Latini P, Reisner Y, Martelli MF.
    N Engl J Med; 1998 Oct 22; 339(17):1186-93. PubMed ID: 9780338
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Canadian multicenter pilot trial of haploidentical donor transplantation.
    Walker I, Shehata N, Cantin G, Couture F, Dhédin N, Barty R, Foley R, Sutherland RD, Sigouin C, Schultz KR, Mitchell D, Canadian Blood and Marrow Transplant Group.
    Blood Cells Mol Dis; 2004 Oct 22; 33(3):222-6. PubMed ID: 15528135
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Sequential regimen of chemotherapy, reduced-intensity conditioning for allogeneic stem-cell transplantation, and prophylactic donor lymphocyte transfusion in high-risk acute myeloid leukemia and myelodysplastic syndrome.
    Schmid C, Schleuning M, Ledderose G, Tischer J, Kolb HJ.
    J Clin Oncol; 2005 Aug 20; 23(24):5675-87. PubMed ID: 16110027
    [Abstract] [Full Text] [Related]

  • 8. A modified haploidentical nonmyeloablative transplantation without T cell depletion for high-risk acute leukemia: successful engraftment and mild GVHD.
    Guo M, Sun Z, Sun QY, Han Q, Yu CL, Wang DH, Qiao JH, Chen B, Sun WJ, Hu KX, Liu GX, Liu B, Zhao RC, Ai H.
    Biol Blood Marrow Transplant; 2009 Aug 20; 15(8):930-7. PubMed ID: 19589482
    [Abstract] [Full Text] [Related]

  • 9. Cord blood transplantation from unrelated donors in adults with high-risk acute myeloid leukemia.
    Sanz J, Sanz MA, Saavedra S, Lorenzo I, Montesinos P, Senent L, Planelles D, Larrea L, Martín G, Palau J, Jarque I, Martínez J, de la Rubia J, Moscardó F, Romero M, Luna I, Montava A, Cañabate S, Sanz GF.
    Biol Blood Marrow Transplant; 2010 Jan 20; 16(1):86-94. PubMed ID: 19744570
    [Abstract] [Full Text] [Related]

  • 10. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL.
    Dan Med Bull; 2007 May 20; 54(2):112-39. PubMed ID: 17521527
    [Abstract] [Full Text] [Related]

  • 11. Successful prevention of acute graft-versus-host disease using low-dose antithymocyte globulin after mismatched, unrelated, hematopoietic stem cell transplantation for acute myelogenous leukemia.
    Kim HJ, Min WS, Cho BS, Eom KS, Kim YJ, Min CK, Lee S, Cho SG, Jin JY, Lee JW, Kim CC.
    Biol Blood Marrow Transplant; 2009 Jun 20; 15(6):704-17. PubMed ID: 19450755
    [Abstract] [Full Text] [Related]

  • 12. Mismatched T cell-depleted hematopoietic stem cell transplantation for children with high-risk acute leukemia.
    Aversa F, Terenzi A, Felicini R, Tabilio A, Falzetti F, Carotti A, Falcinelli F, Sodani P, Amici A, Zucchetti P, Mazzarino I, Martelli MF.
    Bone Marrow Transplant; 1998 Dec 20; 22 Suppl 5():S29-32. PubMed ID: 9989886
    [Abstract] [Full Text] [Related]

  • 13. Transplantation of CD34+ selected peripheral blood to HLA-identical sibling patients with aplastic anaemia: results from a single institution.
    de la Rubia J, Cantero S, Sanz GF, Remigia MJ, Monteagudo E, Moscardó F, Martín G, Lorenzo I, Jiménez C, Martínez J, Montesinos P, Jarque I, Sanz MA.
    Bone Marrow Transplant; 2005 Aug 20; 36(4):325-9. PubMed ID: 15968276
    [Abstract] [Full Text] [Related]

  • 14. The haploidentical option for high-risk haematological malignancies.
    Aversa F, Reisner Y, Martelli MF.
    Blood Cells Mol Dis; 2008 Aug 20; 40(1):8-12. PubMed ID: 17905610
    [Abstract] [Full Text] [Related]

  • 15. Role of antithymocyte globulin and granulocyte-colony stimulating factor-mobilized bone marrow in allogeneic transplantation for patients with hematologic malignancies.
    Chen XH, Zhang C, Zhang X, Gao L, Gao L, Kong PY, Peng XG, Qi DG, Sun AH, Zeng DF, Liu H, Gong Y, Wang QY.
    Biol Blood Marrow Transplant; 2009 Feb 20; 15(2):266-73. PubMed ID: 19167687
    [Abstract] [Full Text] [Related]

  • 16. Haploidentical stem cell transplantation for children with acute leukaemia.
    Marks DI, Khattry N, Cummins M, Goulden N, Green A, Harvey J, Hunt LP, Keen L, Robinson SP, Steward CG, Cornish JM.
    Br J Haematol; 2006 Jul 20; 134(2):196-201. PubMed ID: 16846478
    [Abstract] [Full Text] [Related]

  • 17. Haploidentical transplantation for acute lymphoblastic leukemia in childhood.
    Klingebiel T, Handgretinger R, Lang P, Bader P, Niethammer D.
    Blood Rev; 2004 Sep 20; 18(3):181-92. PubMed ID: 15183902
    [Abstract] [Full Text] [Related]

  • 18. Selected CD34 blood cell allografts for older patients: low transplant-related mortality, graft failure and acute GvHD.
    Roberts MM, Dyson P, Rawling C, Thorp D, Rawling T, White D, Horvath N, Bardy P, Hui CH, Dart GW, To LB, Hughes TP.
    Cytotherapy; 2003 Sep 20; 5(6):534-41. PubMed ID: 14660049
    [Abstract] [Full Text] [Related]

  • 19. Unrelated cord blood transplantation after myeloablative conditioning in adults with acute myelogenous leukemia.
    Ooi J, Takahashi S, Tomonari A, Tsukada N, Konuma T, Kato S, Kasahara S, Sato A, Monma F, Nagamura F, Iseki T, Tojo A, Asano S.
    Biol Blood Marrow Transplant; 2008 Dec 20; 14(12):1341-7. PubMed ID: 19041055
    [Abstract] [Full Text] [Related]

  • 20. Sustained remissions of high-risk acute myeloid leukemia and myelodysplastic syndrome after reduced-intensity conditioning allogeneic hematopoietic transplantation: chronic graft-versus-host disease is the strongest factor improving survival.
    Valcárcel D, Martino R, Caballero D, Martin J, Ferra C, Nieto JB, Sampol A, Bernal MT, Piñana JL, Vazquez L, Ribera JM, Besalduch J, Moraleda JM, Carrera D, Brunet MS, Perez-Simón JA, Sierra J.
    J Clin Oncol; 2008 Feb 01; 26(4):577-84. PubMed ID: 18086801
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.